Skip Nav Destination
Ruxolitinib in CMML: Study Shows Promising Results
December 30, 2021
Content License:Private
Keywords:
Eric Padron, MD, shares results from the phase I study of ruxolitinib in chronic myelomonocytic leukemia, a rare type of myelodysplastic, myeloproliferative neoplasm with few treatment options.